ARTICLE | Company News
Inflazyme, Hoechst Marion Roussel Inc. deal
May 17, 1999 7:00 AM UTC
The companies finalized their previously announced letter of intent to develop compounds to treat allergies, asthma and respiratory diseases using compounds from IZP's IPL576 class of small molecules ...